Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
TCR2 Therapeutics, Inc.
About TCRR
TCR2 Therapeutics Inc. is a clinical-stage immunotherapy company developing T cell therapies for patients suffering from cancer. The Company's T cell receptor (TCR) Fusion Construct T cells (TRuC-T cells) specifically recognize and kill cancer cells by harnessing the entire T cell receptor (TCR) signaling complex. Its lead TRuC-T cell, which targets solid tumors is gavocabtagene autoleucel (gavo-cel). The Company completed the Phase I portion of its Phase I/II clinical trial for gavo-cel to treat patients with non-small cell lung cancer (NSCLC), ovarian cancer, malignant pleural/peritoneal mesothelioma and cholangiocarcinoma. Its other product candidates include TC-510 and TC-520. Its TC-510 is a TRuC-T cell targeting mesothelin-expressing solid tumors which incorporates a PD-1:CD28 chimeric switch receptor. Its TC-520 is the Company’s TRuC-T cell targeting CD-70-expressing solid and liquid tumors which incorporates IL-15 pathway enhancements designed to improve T-cell persistence.
Find out what a historical investment in TCR2 Therapeutics, Inc. would be worth today using our TCRR stock calculator.
Market Capitalisation
-
Price-earnings ratio
-
Dividend yield
-
Volume
-
High today
-
Low today
-
Open price
-
52-week high
-
52-week low
-
Ready to start your investing journey with Stake?
Open an accountHow do I buy TCRR shares in Australia?
Buying TCRR shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in TCR2 Therapeutics, Inc. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in TCRR
What is the ticker symbol of TCR2 Therapeutics, Inc.?
The ticker symbol for TCR2 Therapeutics, Inc. is TCRR.
How much is one share of TCRR?
One share of TCRR is valued at $1.56 as of 22 May 2026.
What is the market capitalisation of TCR2 Therapeutics, Inc. TCRR?
As of 22 May 2026 TCR2 Therapeutics, Inc. has a market cap of -.
What is the 52-week high for TCR2 Therapeutics, Inc. stock?
The TCR2 Therapeutics, Inc. 52-week high stock price is $NaN.
What is the 52-week low for TCR2 Therapeutics, Inc. stock?
The TCR2 Therapeutics, Inc. 52-week low stock price is $NaN.
Can I buy TCRR shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy TCRR shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in TCRR on Stake
- Buy TCRR from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of TCRR from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
TCRR related stocks